Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P230005/S003

Motiva SmoothSilkRound; Round Ergonomix Silicone Gel-Filled Breast Implants

Motiva USA, LLC · Decision date Dec 17, 2025

FDA DECISIONP230005/S003

What did the FDA decide?

FDA records P230005/S003 as a supplement to PMA P230005, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Dec 17, 2025.

FDA approval order statement

Motiva seeks approval for addition of a manufacturing site.
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
General, Plastic Surgery
Decision date
Dec 17, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P230005/S003
Regulatory pathway
PMA supplement
Product code
FTR
Decision code
OK30
Decision date
Dec 17, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, breast, noninflatable, internal, silicone gel-filled.

Product code
FTR
FDA device class
3

For the original device and its historical approval scope, see PMA P230005. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P230005 · Original PMA

    Motiva SmoothSilk Round Ergonomix Silicone Gel-Filled Breast Implants, Motiva SmoothSilk Round Silicone Gel-Filled Breas

  2. P230005/S003 received

    Application receipt date recorded by FDA.

  3. P230005/S003 · FDA decision

    30-Day Notice

  4. P230005/S005 · Related supplement

    Motiva SmoothSilk Round and Round Ergonomix Silicone Gel-Filled Breast Implants

  5. P230005/S002 · Related supplement

    Motiva SmoothSilk Round Ergonomix Silicone Gel-Filled Breast Implants, Motiva SmoothSilk Round Silicone Gel-Filled Breas

Timeline entries are records held by MedtechLedger for P230005. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P230005

Explore the linked device profile

Other records with product code FTR

Product / regulatory recordCompanyPathwayDecision dateSource
Tiger Aesthetics Medical, LLCPMA supplementNov 4, 2026FDA
Mentor Corp.PMA supplementOct 23, 2026FDA
Mentor Worldwide, LLCPMA supplementOct 23, 2026FDA
AllerganPMA supplementSep 29, 2026FDA
Mentor Corp.PMA supplementJul 21, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Motiva USA, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2543 Mesa School Ln., Santa Barbara, CA, 93109

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records